Darwin Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25
Closed -$622 – 1196
2026
Q2
$622 Hold
25
– – ﹤0.01% 587
2026
Q1
$350 Hold
25
– – ﹤0.01% 566
2025
Q4
$280 Hold
25
– – ﹤0.01% 609
2025
Q3
$289 Hold
25
– – ﹤0.01% 573
2025
Q2
$306 Hold
25
– – ﹤0.01% 569
2025
Q1
$398 Hold
25
– – ﹤0.01% 592
2024
Q4
$398 Hold
25
– – ﹤0.01% 592
2024
Q3
$601 Buy
+25
New +$571 ﹤0.01% 587
2020
Q2
– Sell
-25
Closed – – 199
2020
Q1
$0 Buy
+25
New +$747 ﹤0.01% 789

Other funds holding AVNS

Darwin Wealth Management's AVNS Position: Q3 2026 in Review

Darwin Wealth Management sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 25 shares — an estimated $622 sold.

Darwin Wealth Management first reported a position in AVNS in Q1 2020 and held it in 9 quarters. The position peaked at $622 in Q2 2026. 4 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Darwin Wealth Management reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Darwin Wealth Management sold 25 Avanos Medical shares in Q3 2026, an estimated $622.
  • Darwin Wealth Management first reported a position in Avanos Medical in Q1 2020 and held it in 9 quarters.
  • Darwin Wealth Management's Avanos Medical position peaked at $622 in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.